Terms: = Pancreatic cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Clinical Outcome
39 results:
1. Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer.
Reissig TM; Tzianopoulos I; Liffers ST; Rosery VK; Guyot M; Ting S; Wiesweg M; Kasper S; Meister P; Herold T; Schmidt HH; Schumacher B; Albers D; Markus P; Treckmann J; Schuler M; Schildhaus HU; Siveke JT
ESMO Open; 2023 Jun; 8(3):101539. PubMed ID: 37148593
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma.
Ji R; Ng KK; Chen W; Yang W; Zhu H; Cheung TT; Chiang CL; Wong TCL; Kong FM; Wu G; Lo CM
Medicine (Baltimore); 2022 Jan; 101(4):e28545. PubMed ID: 35089192
[TBL] [Abstract] [Full Text] [Related]
3. Patient volume and clinical outcome after pancreatic cancer resection: A contemporary systematic review and meta-analysis.
Ratnayake B; Pendharkar SA; Connor S; Koea J; Sarfati D; Dennett E; Pandanaboyana S; Windsor JA
Surgery; 2022 Jul; 172(1):273-283. PubMed ID: 35034796
[TBL] [Abstract] [Full Text] [Related]
4. Accuracy and other quality indicators of solid pancreatic mass endoscopic ultrasound-guided fine needle aspiration and biopsy in two academic endoscopy centers.
Figueiredo M; Arvanitakis M; Zaarour A; Toussaint E; Devière J; Van Laethem JL; Gomez-Galdon M; Verset L; Demetter P; Eisendrath P
Acta Gastroenterol Belg; 2021; 84(3):451-455. PubMed ID: 34599570
[TBL] [Abstract] [Full Text] [Related]
5. SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma.
Fei N; Wen S; Ramanathan R; Hogg ME; Zureikat AH; Lotze MT; Bahary N; Singhi AD; Zeh HJ; Boone BA
Clin Transl Sci; 2021 Sep; 14(5):1822-1829. PubMed ID: 34002944
[TBL] [Abstract] [Full Text] [Related]
6. Impact of surgeon work duration prior to distal pancreatectomy on perioperative outcomes: a propensity score matching analysis.
Wan Z; Wang X; Li Y; Wan R
BMC Surg; 2021 Jan; 21(1):54. PubMed ID: 33482805
[TBL] [Abstract] [Full Text] [Related]
7. Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign?
Belfiori G; Fiorentini G; Tamburrino D; Partelli S; Pagnanelli M; Gasparini G; Castoldi R; Balzano G; Rubini C; Zamboni G; Crippa S; Falconi M
Surgery; 2021 Feb; 169(2):403-410. PubMed ID: 32912782
[TBL] [Abstract] [Full Text] [Related]
8. Needle Catheter Jejunostomy in Patients Undergoing Surgery for Upper Gastrointestinal and Pancreato-Biliary cancer-Impact on Nutritional and clinical outcome in the Early and Late Postoperative Period.
Wobith M; Wehle L; Haberzettl D; Acikgöz A; Weimann A
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854177
[TBL] [Abstract] [Full Text] [Related]
9. YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma.
Tu B; Yao J; Ferri-Borgogno S; Zhao J; Chen S; Wang Q; Yan L; Zhou X; Zhu C; Bang S; Chang Q; Bristow CA; Kang Y; Zheng H; Wang H; Fleming JB; Kim M; Heffernan TP; Draetta GF; Pan D; Maitra A; Yao W; Gupta S; Ying H
JCI Insight; 2019 Nov; 4(21):. PubMed ID: 31557131
[TBL] [Abstract] [Full Text] [Related]
10. External validation of the Japanese difficulty scoring system for minimally-invasive distal pancreatectomies.
Goh BKP; Kabir T; Koh YX; Teo JY; Lee SY; Kam JH; Cheow PC; Jeyaraj PR; Chow PKH; Ooi LLPJ; Chung AYF; Chan CY
Am J Surg; 2019 Nov; 218(5):967-971. PubMed ID: 30910129
[TBL] [Abstract] [Full Text] [Related]
11. Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.
Zhang J; Kulkarni HR; Singh A; Niepsch K; Müller D; Baum RP
J Nucl Med; 2019 Mar; 60(3):377-385. PubMed ID: 30115686
[TBL] [Abstract] [Full Text] [Related]
12. clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer.
Albano D; Familiari D; Gentile R; Scalisi S; Midiri F; Messina M; Spada M; Fornito MC; Galia M; Midiri M; Alongi P
Nucl Med Commun; 2018 Aug; 39(8):741-746. PubMed ID: 29782393
[TBL] [Abstract] [Full Text] [Related]
13. clinical Usefulness of
Rinzivillo M; Partelli S; Prosperi D; Capurso G; Pizzichini P; Iannicelli E; Merola E; Muffatti F; Scopinaro F; Schillaci O; Salgarello M; Falconi M; Delle Fave G; Panzuto F
Oncologist; 2018 Feb; 23(2):186-192. PubMed ID: 29118267
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma.
Inaguma S; Wang Z; Lasota J; Onda M; Czapiewski P; Langfort R; Rys J; Szpor J; Waloszczyk P; Okoń K; Biernat W; Ikeda H; Schrump DS; Hassan R; Pastan I; Miettinen M
Oncotarget; 2017 Apr; 8(16):26744-26754. PubMed ID: 28460459
[TBL] [Abstract] [Full Text] [Related]
15. New structural and functional insight into the regulation of Ras.
Kano Y; Cook JD; Lee JE; Ohh M
Semin Cell Dev Biol; 2016 Oct; 58():70-8. PubMed ID: 27297135
[TBL] [Abstract] [Full Text] [Related]
16. Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer.
Yang SH; Guo JC; Yeh KH; Tien YW; Cheng AL; Kuo SH
J Gastroenterol Hepatol; 2016 Dec; 31(12):2004-2012. PubMed ID: 27059987
[TBL] [Abstract] [Full Text] [Related]
17. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
Int J Oncol; 2016 May; 48(5):1955-64. PubMed ID: 26935290
[TBL] [Abstract] [Full Text] [Related]
18. clinical outcome of elderly patients with unresectable pancreatic cancer treated with gemcitabine plus S-1, S-1 alone, or gemcitabine alone: Subgroup analysis of a randomised phase III trial, GEST study.
Imaoka H; Kou T; Tanaka M; Egawa S; Mizuno N; Hijioka S; Hara K; Yazumi S; Shimizu Y; Yamao K
Eur J Cancer; 2016 Feb; 54():96-103. PubMed ID: 26741729
[TBL] [Abstract] [Full Text] [Related]
19. CD24 and APC Genetic Polymorphisms in pancreatic cancers as Potential Biomarkers for clinical outcome.
Shamai S; Nabiochtchikov I; Kraus S; Zigdon S; Kazanov D; Itzhak-Klutch M; Eizner C; Arber N; Geva R
PLoS One; 2015; 10(9):e0134469. PubMed ID: 26394139
[TBL] [Abstract] [Full Text] [Related]
20. Exocrine pancreatic carcinoma in Tunisia: A retrospective study about 158 cases.
El Guesmi S; Ben Nasr S; Afrit M; Labidi S; Boussen H
Tunis Med; 2015 Feb; 93(2):73-5. PubMed ID: 26337302
[TBL] [Abstract] [Full Text] [Related]
[Next]
